Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Mereo BioPharma (MREO) over the last 2 years, with Q2 2025 value amounting to 1593.8%.

  • Mereo BioPharma's EBITDA Margin changed N/A to 1593.8% in Q2 2025 from the same period last year, while for Sep 2025 it was 12930.94%, marking a year-over-year decrease of 94477400.0%. This contributed to the annual value of 252.64% for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Mereo BioPharma's EBITDA Margin is 1593.8%.
  • Over the past 5 years, Mereo BioPharma's EBITDA Margin peaked at 5182.22% during Q1 2025, and registered a low of 1593.8% during Q2 2025.